Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour versus 24-hour magnesium sulfate in PPROM before 32 weeks
IRCT20241229064202N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of magnesium sulfate in Preterm prelabor rupture of membranes (PPROM) (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Birth weight, Umbilical cord pH and 5 more. Started Dec 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on IRCT20241229064202N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241229064202N1.